Literature DB >> 6709136

Cerebrospinal fluid ascorbic acid levels in neurological disorders.

R H Brau, S García-Castiñeiras, N Rifkinson.   

Abstract

The ascorbic acid/dehydroascorbic acid system was analyzed in the cerebrospinal fluid (CSF) of 41 patients with different neurological disorders. The chi-square test of covariance analysis revealed in this sample significant differences in the CSF levels of total ascorbic acid when patients were classified by diagnostic categories. The population analyzed contained a group of 18 patients (back pain/sciatica group) in whom no overt neurological abnormalities were disclosed upon evaluation. Taking the CSF levels of total ascorbic acid and dehydroascorbic acid in these patients as the reference (3.57 +/- 0.87 (SD)/100 ml and 0.53 +/- 0.19 mg/100 ml, respectively), it was found that head-traumatized patients showed a significant reduction in the concentration of total ascorbic acid in the CSF. CSF ascorbic acid levels were also significantly lower in patients with increased intracranial pressure (noninfected hydrocephalus group) and in patients with cerebral tumors. Although the CSF concentration of dehydroascorbic acid did not correspondingly increase over the reference values in these three groups of patients, the tendency existed for dehydroascorbic acid to represent in them a higher percentage of total ascorbic acid. After examining different alternatives, it is concluded that the hypothesis of free radical damage to the central nervous system after certain types of injury (trauma, ischemia, and tumors) may provide a satisfactory explanation of our findings. A rationale for the use of vitamin C in the management of some neurological patients is also derived from this work.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6709136     DOI: 10.1227/00006123-198402000-00004

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

1.  Normal ascorbic acid in cerebrospinal fluid of patients with infantile neuronal ceroid-lipofuscinosis.

Authors:  J O Sass; D Skladal; M Brunner-Krainz
Journal:  Metab Brain Dis       Date:  1999-03       Impact factor: 3.584

2.  The significance of electron spin resonance of the ascorbic acid radical in freeze dried human brain tumours and oedematous or normal periphery.

Authors:  H W Mueller; S Tannert
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

3.  Influence of Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Oxidative Stress Intensity in Minimally Conscious State Patients.

Authors:  Katarzyna Jezierska-Wozniak; Emilia Sinderewicz; Wioleta Czelejewska; Pawel Wojtacha; Monika Barczewska; Wojciech Maksymowicz
Journal:  J Clin Med       Date:  2020-03-03       Impact factor: 4.241

4.  High-Dose Intravenous Ascorbic Acid: Ready for Prime Time in Traumatic Brain Injury?

Authors:  Stefan W Leichtle; Anand K Sarma; Micheal Strein; Vishal Yajnik; Dennis Rivet; Adam Sima; Gretchen M Brophy
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.